Advanced Search

Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2010 February;76(2) > Minerva Anestesiologica 2010 February;76(2):115-9



A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036

Frequency: Monthly

ISSN 0375-9393

Online ISSN 1827-1596


Minerva Anestesiologica 2010 February;76(2):115-9


The pharmacodynamic effects of rocuronium during general anesthesia in patients with type 2 diabetes mellitus

Alper I., Ulukaya S., Makay O., Balcioglu T.

Department of Anesthesiology and Reanimation, Ege University School of Medicine, Izmir, Turkey

AIM. The aim of this prospective study was to investigate whether the neuromuscular response to rocuronium is affected by the presence of type 2 diabetes mellitus.
METHODS: Neuromuscular functions were measured after the administration of 0.6 mg/kg rocuronium with train-of-four stimulations in patients with type 2 diabetes mellitus (DM, N=14) and without diabetes mellitus (control, N=14) during isoflurane based general anesthesia. The onset time, clinical duration and recovery index of rocuronium were compared in the two groups.
RESULTS: The mean onset time (136 ± 40 vs 118 ± 20 s), clinical duration (51 ± 11 vs 48 ± 11 min) and recovery index (6.0 ± 2.5 vs 5.9 ± 1.4 min) of the neuromuscular block were not significantly different between the DM and control groups, respectively (p>0.05).
CONCLUSIONS: The present study has proven that the rocuronium-induced neuromuscular block was not affected in patients with type 2 diabetes mellitus during isoflurane based general anesthesia.

language: English


top of page